Résumé
la présente circulaire a pour objet d’acutualiser les recommandations visant à réduire les risques de transmission d’agents transmissibles non conventionnels de lacirculaire DGS/DH no 100 du 11 décembre 1995.
Référence
BROWN P., Rohwer R.G., GAJDUSEK D.C. — Newer data on the inactivation of scrapie virus or Creutzfeldt-Jakob disease in brain tissue.J. Infect. Disease, 1986,153, 1145–1148.
WILL R.G., IRONSIDE J.W., ZEIDLER M., COUSENS S.N., ESTIBEIRO K., ALPÉROVITCH A.et al. — A new variant of Creutzfeldt-Jakob disease in the UK.Lancet, 1996,347, 921–925.
CHAZOT G., BROUSSOLE E., BLATTIER T., AGUZZI A., KOPP N. — New variant of Creutzfeldt-Jakob disease in a 26-year old French man.Lancet, 1996,347, 1181.
RUTALA W. — APIC guideline for selection and use of disinfectants.Am. J. Infect. Control & Steriliz Technol., 1996,24, 313–336.
BRUCE M.E., WILL R.G., IRONSIDE J.W., M.C. CONNELL I., DRUMMOND D., SUTTIE A.,et al. — Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent.Nature, 1997,389, 498–501.
HILTON D.A., FATHERS E., EDWARDS P., IRONSIDE J.W., ZAJICEK J. — Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease.Lancet, 1998,352, 703–704.
DARBORD J.C. — Inactivation of prions in daily medical practice.Biomed & Pharmacother, 1999,53, 34–38.
INGROSSO L., PISANI F., POCCHIARI M. — Transmission of the 263K scrapie strain by the dental route.Journal of General Virology, 1999,80, 3043–3047.
SCOTT M., WILL R., IRONSIDE J., NAUYEN H.O.B., TREMBLAY P., DEARMOND S.et al. — Compelling transgenic evidence for transmission of bovine spongiform encephalopathy prions to humans.Proc. Natl. Acad Sci. USA, 1999,96, 15137–15142.
HILL A.F. BUTTERWORTH R.J., JOINER S., JACKSON G., ROSSOR M.N., THOMAS D.J.et al. — Investigation of variant Creutzfeldt-Jakob disease and other prion diseases with tonsil biopsy samples.Lancet, 1999,353, 183–189.
TAYLOR D.M. — Inactivation of prions by physical and chemical means.Journal of Hospital Infection, 1999,43, S69-S76.
GILL N. — Developments in variant Creutzfeldt-Jakob disease.Eurosurveillance, 2000,5, 89–90.
GHANI A.C., FERGUSON N.M., DONNELLY C.A., ANDERSON R.M. — Predicted vCJD mortality in Great Britain.Nature, 2000,406, 583–584.
DORRNONT D. — Le nouveau variant de la maladie de Creutzfeldt-Jakob.Eurosurveillance, 2000,5, 95–97.
HOUSTON F., FOSTER J.D., CHONG A., HUNTER N., BOSTOCK C.J. — Transmission of BSE by blood transfusion in sheep.Lancet, 2000,356, 999–1000.
BLANDQUET-GROSSARD F., SAZDOVITCH V., JEAN A., DESLYS J.P., DORMONT D., HAUW J.J., MARION D., BROWN P., CESBRON J.Y. — Prion protein is not detectable in dental pulp from patients with Creutzfeldt-Jakob disease.J. Dent. Res., 2000,79 (2), 700.
ANDREWS N.J., FARRINGTON C.P., COUSENS S.N., SMITH P.G., WARD H., KNIGHT R.S.G., IRONSIDE J.W., WILL R.G. — Incidence of variant Creut7ièldt-Jakob disease in the UK.Lancet, 2000,356, 481–482.
BROWN P., PREECE M., BRANDEL J.P., SATO T., MCSHANE L., ZERR I, FLETCHER A., WILL R.G., POCCHIARI M., CASHINAN N.R., D’AIGNAUX J.H., CERVENAKOVA L., FRADKIN J., SCHONBERGER L.B., COLLINS S.J. — Iatrogenic Creutzfeldt-Jakob disease at the millenium.Neurology, 2000,55 (8), 1075–1081.
TAYLOR D.M. — Inactivation of transmissible degenerative encephalopathy agents: a review.V.et J., 2000,159, 10–17.
ANTLOGA K., MESZAROS J., MALCHESKY P.S., MCDONNELL G.E. — Prion disease and medical devices.ASAIO J, 2000,46, 69–72.
Avis et rapports du CSHPF, du CTIN et du CIESST sur la sécurité des endoscopes (Rapports du 30 septembre et du 18 octobre 1999 du groupe de travail tripartite CSHPF-CTIN-CIESST: avis du CIESST du 22 décembre 1999; avis du CIESST du 24 décembre 2000). L’ensemble de ces documents est consultable sur le site Internet du ministère http: //www.sante.gouv.fr.
WHO Infection Control Guidelines for Transmissible Spongiform Encephalopathies. Report of a WHO Consultation, Geneva, Switzerland, 23–26 March 1999. Ce document est consultable sur le site Internet de l’OMS http://www.who.ch.
About this article
Cite this article
Guigou, E., Kouchiner, B. Circulaire no DGS/5C/DHOS/E2/2001/138 du 14 mars 2001 relative aux précautions à observer lors de soins en vue de réduire les risques de transmission d’agents transmissibles non conventionnels. Acta Endosc 32 (Suppl 2), 474–485 (2002). https://doi.org/10.1007/BF03020302
Issue Date:
DOI: https://doi.org/10.1007/BF03020302